BCM
Bayesian Capital Management’s AstraZeneca AZN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-32,100
| Closed | -$2.1M | – | 612 |
|
|
2024
Q4 | $2.1M | Buy |
+32,100
| New | +$2.1M | 0.26% | 115 |
|
|
2024
Q3 | – | Sell |
-26,900
| Closed | -$2.1M | – | 685 |
|
|
2024
Q2 | $2.1M | Buy |
26,900
+23,500
| +691% | +$1.83M | 0.24% | 107 |
|
|
2024
Q1 | $230K | Sell |
3,400
-6,700
| -66% | -$454K | 0.02% | 626 |
|
|
2023
Q4 | $680K | Sell |
10,100
-7,700
| -43% | -$519K | 0.07% | 317 |
|
|
2023
Q3 | $1.21M | Sell |
17,800
-32,500
| -65% | -$2.2M | 0.14% | 184 |
|
|
2023
Q2 | $3.6M | Buy |
50,300
+8,829
| +21% | +$632K | 0.39% | 46 |
|
|
2023
Q1 | $2.88M | Buy |
+41,471
| New | +$2.88M | 0.36% | 73 |
|
|
2022
Q2 | – | Sell |
-30,939
| Closed | -$2.05M | – | 785 |
|
|
2022
Q1 | $2.05M | Buy |
30,939
+16,839
| +119% | +$1.12M | 0.31% | 61 |
|
|
2021
Q4 | $821K | Sell |
14,100
-15,400
| -52% | -$897K | 0.26% | 118 |
|
|
2021
Q3 | $1.77M | Buy |
+29,500
| New | +$1.77M | 0.51% | 44 |
|
|
2020
Q3 | – | Sell |
-16,497
| Closed | -$873K | – | 519 |
|
|
2020
Q2 | $873K | Buy |
16,497
+10,641
| +182% | +$563K | 0.19% | 150 |
|
|
2020
Q1 | $262K | Sell |
5,856
-46,000
| -89% | -$2.06M | 0.06% | 506 |
|
|
2019
Q4 | $2.59M | Buy |
+51,856
| New | +$2.59M | 0.44% | 43 |
|
|
2019
Q3 | – | Sell |
-17,756
| Closed | -$733K | – | 514 |
|
|
2019
Q2 | $733K | Sell |
17,756
-49,200
| -73% | -$2.03M | 0.15% | 189 |
|
|
2019
Q1 | $2.71M | Buy |
66,956
+35,743
| +115% | +$1.45M | 0.52% | 43 |
|
|
2018
Q4 | $1.19M | Buy |
+31,213
| New | +$1.19M | 0.24% | 124 |
|
|
2016
Q4 | – | Sell |
-12,200
| Closed | -$401K | – | 597 |
|
|
2016
Q3 | $401K | Buy |
+12,200
| New | +$401K | 0.26% | 137 |
|